Global Shifts Impacting ADC Service Providers and Developers
As antibody-drug conjugates gain momentum across global clinical pipelines, the ecosystem supporting their development is undergoing accelerated transformation. Biopharmaceutical innovators are becoming increasingly reliant on advanced manufacturing partners capable of producing complex, highly potent therapeutics with uncompromising precision. More companies are shifting their development...
0 Comentários 0 Compartilhamentos 791 Visualizações 0 Anterior